Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
Determine the safety of a combination of IFN, celecoxib, and rintatolimod for patients with recurrent colorectal cancer. This will also test whether the above combination can help the immune system to fight the tumors. The results will allow the investigators to determine the \"preferred\" combination for subsequent extended studies.
Epistemonikos ID: 339bde130625f8d51a256b06f7ed8403bc756ca6
First added on: May 10, 2024